To compare prostate cancer detection rates between end-fire and side-fire ultrasound guided prostate biopsy techniques. A prospective randomized controlled trial was performed in patients who underwent prostate biopsy between 2009 and 2014. Patients were randomly assigned to the end-fire or side fire biopsy groups and underwent transrectal ultrasound guided prostate biopsy. The overall prostate cancer detection rate was compared between the two probe configurations. Trial was registered at Clinical Trials.gov with identifier: NCT00851292. A total of 730 patients were included and randomized, 371 patients underwent prostate biopsy with side-fire probe and 359 patients with the end-fire probe. Prostate cancer detection rates were 52.4% in the end fire group and 45.6% in the side fire group ( = .066). No significant difference was found in detection rate of prostate cancer between the end-fire and side-fire probe in transrectal ultrasound guided prostate biopsy, neither for detection rate of prostate cancer in the apex.
Neostigmine treatment induces neuroprotection against oxidative stress in cerebral cortex of asthmatic mice.
March 20, 2020
Evolution of Fatigue Damage in the L5-S1 Intervertebral Disc Resulting from Walking Exposures Among Persons with Lower Limb Loss.
March 2, 2020
Short-term effects of air pollution on daily asthma-related emergency department visits in an industrial city.
March 23, 2020
Related Meeting Coverage
- ASCO 2019The 2019 ASCO Annual Meeting, taking place May 31-June 4 in Chicago, will bring together more than 32,000 oncology professionals from across the globe. The theme of this year’s conference is Caring for Every Patient, Learning From Every Patient.